Alliance Pharma PLC
LSE:APH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biohit Oyj
OMXH:BIOBV
|
FI |
Alliance Pharma PLC
Total Current Liabilities
Alliance Pharma PLC
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Total Current Liabilities
£36.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Total Current Liabilities
£21.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Total Current Liabilities
$30.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Current Liabilities
$1.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Total Current Liabilities
£27.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
|
Animalcare Group PLC
LSE:ANCR
|
Total Current Liabilities
£21.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
24%
|
|
Alliance Pharma PLC
Glance View
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).
See Also
What is Alliance Pharma PLC's Total Current Liabilities?
Total Current Liabilities
36.7m
GBP
Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Total Current Liabilities amounts to 36.7m GBP.
What is Alliance Pharma PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
12%
Over the last year, the Total Current Liabilities growth was -10%. The average annual Total Current Liabilities growth rates for Alliance Pharma PLC have been -3% over the past three years , 9% over the past five years , and 12% over the past ten years .
